Pediatric Cancer in a Post-genomic World (March 30-April 1, 2016)

To learn more about this conference, go to : Events Details at www.nyas.org.

Keynote Address Overview

  • The Successes and Future Direction of Pediatric Cancer Research and Therapy.
    Richard Gilbertson, MD, PhD, Cambridge Cancer Center, The University of Cambridge
  • The Role of Epigenetic and Metabolic Mutations in Stem Cell Maintenance and Pediatric Cancers.  Craig B. Thompson, MD, Memorial Sloan Kettering Cancer Center

Session Overview

  1. The Evolving Landscape of Pediatric Cancer Genomes
  2. Epigenetic and Chromatin Remodeling as Disease Drivers in Pediatric Cancer
  3.  Germline Alterations and Cancer Susceptibility in Pediatric Patients
  4. Insights into Metabolic Reprogramming in Pediatric Cancer
  5. Clonal Selection and Stress Adaptation as Drivers of Metastasis in Pediatric Cancers
  6. Immunotherapeutic Approaches to Pediatric Malignancies
  7. New Paradigms in Modeling Pediatric Cancer
  8. Innovative Strategies to Implementing Precision Medicine-based Therapeutic Trials for Pediatric Cancer

 Presented by The Sohn Conference Foundation and the New York Academy of Sciences

Advertisements